1. Badura-Stronka, Magdalena, Kuszel, Łukasz, Wencel-Warot, Agnieszka, Steinborn, Barbara, Płoski, Rafał. 2023. Broadening the phenotypic spectrum of the presumably epilepsy-related SV2A gene variants. In Epilepsy research, 190, 107101. doi:10.1016/j.eplepsyres.2023.107101. https://pubmed.ncbi.nlm.nih.gov/36758444/
2. Ohno, Yukihiro, Tokudome, Kentaro. . Therapeutic Role of Synaptic Vesicle Glycoprotein 2A (SV2A) in Modulating Epileptogenesis. In CNS & neurological disorders drug targets, 16, 463-471. doi:10.2174/1871527316666170404115027. https://pubmed.ncbi.nlm.nih.gov/28393712/
3. Wang, Di, Zhou, Qilin, Ren, Liankun, Du, Jialin, Wang, Yuping. 2019. Levetiracetam-induced a new seizure type in a girl with a novel SV2A gene mutation. In Clinical neurology and neurosurgery, 181, 64-66. doi:10.1016/j.clineuro.2019.03.020. https://pubmed.ncbi.nlm.nih.gov/31005049/
4. Harper, Callista B, Small, Christopher, Davenport, Elizabeth C, Meunier, Frédéric A, Cousin, Michael A. 2020. An Epilepsy-Associated SV2A Mutation Disrupts Synaptotagmin-1 Expression and Activity-Dependent Trafficking. In The Journal of neuroscience : the official journal of the Society for Neuroscience, 40, 4586-4595. doi:10.1523/JNEUROSCI.0210-20.2020. https://pubmed.ncbi.nlm.nih.gov/32341095/
5. Zhang, Yifan, Heylen, Lise, Partoens, Michèle, de Witte, Peter A M, Siekierska, Aleksandra. 2022. Connectivity Mapping Using a Novel sv2a Loss-of-Function Zebrafish Epilepsy Model as a Powerful Strategy for Anti-epileptic Drug Discovery. In Frontiers in molecular neuroscience, 15, 881933. doi:10.3389/fnmol.2022.881933. https://pubmed.ncbi.nlm.nih.gov/35686059/